MedTrace Logo

Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairment

NCT07334392 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-01-12

No results posted yet for this study

Summary

The goal of this randomised clinical trial is to investigate the effectiveness of an innovative therapeutic exercise program emphasizing in dual-task exercises in people with amnestic Mild Cognitive Impairment. The main questions it aims to answer are:

Does the innovative therapeutic exercise program improve gait and balance? Does the innovative therapeutic exercise program improve cognition?

Researchers will compare the innovative therapeutic exercise program emphasizing in dual-task exercises to a therapeutic exercise program without emphasizing in dual-task exercises and to a control group (given instruction about the benefits of exercise).

Participants will:

* Perform the exercise program twice a week for three months.
* Will be assessed before and after the intervention.
* Will record The Borg Scale of Perceived Exertion every second week to monitor and assess the progression of exercise intensity.

Conditions

Interventions

OTHER

Innovative therapeutic exercise program

Aerobic, strengthening and balance exercises combined with cognitive training -name: Experimental group 1 (EXP1)

OTHER

Therapeutic exercise program

Aerobic, strengthening and balance exercises without cognitive training- name: Experimental group 2 (EXP2)

OTHER

Flyer

The control group will receive only educational material in the form of a flyer, outlining the importance and potential benefits of physical activity, along with general lifestyle recommendations, without participating in the structured exercise intervention- name: Control group (CG)

Sponsors & Collaborators

  • General University Hospital of Patras

    collaborator OTHER

  • Andreas Mentzelopoulos Foundation

    collaborator UNKNOWN

  • University of Patras

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-08-30
Completion
2026-11-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07334392 on ClinicalTrials.gov